Related Experiment Video
Updated: Jun 29, 2026
07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
18.6K
Deciphering ovarian cancer heterogeneity through spatial transcriptomics, single-cell profiling, and copy number
Songyun Li1,2, Zhuo Wang1,2, Hsien-Da Huang1,2
1Warshel Institute for Computational Biology, The Chinese University of Hong Kong, Shenzhen, Guangdong, P.R. China.
Plos One
|March 4, 2025
Summary
High-grade serous ovarian carcinoma (HGSOC) is challenging due to multidrug resistance. This study reveals tumor heterogeneity drivers and identifies the MDK-NCL interaction as a key target for HGSOC growth, offering new therapeutic strategies.
Area of Science:
- Oncology
- Genomics
- Cell Biology
Background:
- High-grade serous ovarian carcinoma (HGSOC) presents significant clinical challenges, primarily due to multidrug resistance (MDR) stemming from tumor heterogeneity.
- Understanding the complex mechanisms driving HGSOC heterogeneity is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To comprehensively analyze HGSOC heterogeneity at the levels of gene expression, copy number variation (CNV), and single-cell profiles.
- To identify key cellular interactions and molecular drivers contributing to HGSOC tumor growth and resistance.
Main Methods:
- Integrated analysis of five single-cell transcriptomes and eight spatial transcriptomes from eight HGSOC patients.
- Copy number variation (CNV) analysis to identify tumor clones and their evolutionary trajectories.
- Single-cell RNA sequencing (scRNA seq) to define cellular meta-programs and communication networks.
Main Results:
- CNV analysis revealed distinct tumor clones with varying evolutionary paths and spatial distributions, highlighting intratumor heterogeneity.
- scRNA seq identified three functional meta-programs in tumor cells, with distinct communication networks associated with each.
- The MDK-NCL ligand-receptor pair was identified as a critical interaction promoting tumor cell proliferation, confirmed by NCL overexpression experiments.
Conclusions:
- HGSOC heterogeneity is multifaceted, involving distinct tumor clones and complex cellular communication networks.
- The MDK-NCL interaction is a significant driver of HGSOC tumor growth and represents a potential therapeutic target.
- This research provides insights into HGSOC heterogeneity and suggests novel strategies for combating this malignancy.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...